Sea Moss for Mast Cell Activation Syndrome: Anti-Histamine, Anti-Inflammatory & Stabilization Support

Mast cell activation syndrome (MCAS) is a condition of pathological mast cell mediator release causing multisystem symptoms including flushing, urticaria, GI symptoms, anaphylaxis, and hypotension via histamine, PGD2, tryptase, leukotrienes, and cytokine overproduction. MCAS is driven by KIT mutations (D816V in systemic mastocytosis), IgE hypersensitivity, and mast cell membrane instability. Sea moss fucoidan has mast cell-stabilizing anti-inflammatory properties; quercetin (sea moss bioactive) inhibits histamine release; selenium supports mast cell GPx antioxidant protection; zinc supports mast cell regulation; omega-3 competes with arachidonic acid for leukotriene/PGD2 synthesis. Antihistamines (H1/H2), cromolyn, and mast cell stabilizers are standard; sea moss provides multi-target anti-inflammatory nutritional support alongside specialist care.

Read the full guide